ALPHA 2B OR 2B/2C ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATION
Application 827/KOLNP/2005 published 2006-06-23, filed 2005-05-06
Methods of preventing or retarding the degeneration of neurons. Also disclosed are methods for treating Alzheimer's disease or Parkinson's disease through the administration of selective alpha 2B or alpha 2B/2C receptor agonists, hereby incorporated by reference herein. (FIG). nil
Applicant
ALLERGAN, INC
2525 DUPONT DRIVE, T2-7H, IRVINE, CA 92612, USA.
Inventor
WHEELER LARRY A GIL DANIEL W DONELLO JOHN E
International Info
Classification: A61K 31/17, 31/4174, A61P 25/16, 25/28
Publication Number: WO 04/032913
Application Date: 2003-10-07
Priority Information
60/417,049 US 2002-10-08